Across TCGA pan-cancer cohorts, FABP9 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated FABP9 data layer compared with 18 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher FABP9 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FABP9 expression acts as an unfavorable survival marker.

SKCM and LIHC are the cancer types where FABP9 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Median	II,III,IV	0.336	0.739	<.001	29	view →
LIHC	DFS	Median	All	0.040	0.553	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: FABP9 tumor-vs-normal RNA expression · all FABP9 data types